I agree that this site is using cookies. You can find further informations here.
X
Camidge, D Ross
330  results:
Search for persons X
?
1

The Role of Local Therapy for Oligo-Progressive Disease in ..:

Tsui, David Chun Cheong ; Holt, Douglas E. ; Patil, Tejas...
Advances in Radiation Oncology.  9 (2024)  7 - p. 101516 , 2024
Link: https://doi.org/10.1016/..
 
?
2

CSF Cytology Identifies Mechanisms of Tyrosine Kinase Inhib..:

Jurica, James M. ; Carsten, Billie ; Balakhani, Sudabeh...
Clinical Lung Cancer.  25 (2024)  1 - p. 77-79 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Trial Design and Optimal Determination of CNS Activity of S..:

Jennings, Elaine M. ; Camidge, D. Ross ; Gadgeel, Shirish.
Clinical Lung Cancer.  25 (2024)  2 - p. 91-99 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Mobocertinib: Mechanism of action, clinical, and translatio..:

Hanley, Michael J. ; Camidge, D. Ross ; Fram, Robert J..
Clinical and Translational Science.  17 (2024)  3 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
5

PPD01.02 Repotrectinib in Patients With ROS1 Fusion-Positiv..:

Drilon, Alexander ; Camidge, D. Ross ; Lin, Jessica J....
Journal of Thoracic Oncology.  19 (2024)  7 - p. e4-e5 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Characteristics of Long-Term Survivors With EGFR-Mutant Met..:

Tompkins, William ; Grady, Connor B. ; Hwang, Wei-Ting...
JTO Clinical and Research Reports.  5 (2024)  8 - p. 100669 , 2024
Link: https://doi.org/10.1016/..
 
?
7

L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrecti..:

Weber, Urs ; Davies, Kurtis D. ; Camidge, D. Ross
JTO Clinical and Research Reports.  5 (2024)  7 - p. 100673 , 2024
Link: https://doi.org/10.1016/..
 
?
8

PPD01.07 Phase 2 Trial of Mecbotamab Vedotin (BA3011), a CA..:

Rotow, Julia ; Dy, Grace K. ; Camidge, D. Ross
Journal of Thoracic Oncology.  19 (2024)  7 - p. e7 , 2024
Link: https://doi.org/10.1016/..
 
?
9

PP01.58 Real-world Outcomes in Patients With EGFR Wildtype ..:

Girard, Nicolas ; Xu, Qingqing ; Camidge, D. Ross...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e28 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Blood tumor mutational burden and response to pembrolizumab..:

Bar, Jair ; Esteban, Emilio ; Rodríguez-Abreu, Delvys...
Lung Cancer.  190 (2024)  - p. 107506 , 2024
Link: https://doi.org/10.1016/..
 
?
11

NVTG-09 TARGETING TRKB IN LUNG-TO-BRAIN METASTATIC PROGRESS..:

Contreras-Zárate, Maria J ; Koliavas, Stella ; Heasley, Lynn...
Neuro-Oncology Advances.  6 (2024)  Supplement_1 - p. i25-i25 , 2024
Link: https://doi.org/10.1093/..
 
?
12

Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregn..:

Simons, Emily ; Camidge, D. Ross
Journal of Thoracic Oncology.  19 (2024)  6 - p. 866-876 , 2024
Link: https://doi.org/10.1016/..
 
?
13

The Efficacy and Safety of Treating Acquired MET Resistance..:

Patil, Tejas ; Staley, Alyse ; Nie, Yunan...
JTO Clinical and Research Reports.  5 (2024)  2 - p. 100637 , 2024
Link: https://doi.org/10.1016/..
 
?
14

A Multicenter Retrospective Chart Review of Clinical Outcom..:

Iams, Wade T. ; Balbach, Meridith L. ; Phillips, Sharon...
Clinical Lung Cancer.  24 (2023)  3 - p. 228-234 , 2023
Link: https://doi.org/10.1016/..
 
?
15

CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Tre..:

Kim, Dong-Wan ; Kim, Sang-We ; Camidge, D. Ross...
Journal of Thoracic Oncology.  18 (2023)  5 - p. 650-656 , 2023
Link: https://doi.org/10.1016/..
 
1-15